Jubilant Ingrevia Ltd Q1 FY26 Results

Summary

Jubilant Ingrevia's Q1 FY26 results showed a 54% YoY increase in profit after tax and double-digit growth in specialty chemicals. The global chemical sector is emerging from the inventory de-stocking phase, with specialty chemicals seeing volume growth and commodity segments facing demand challenges. The pharmaceutical and agrochemical sectors continue to grow, and the nutrition market saw stable volumes. The company anticipates continued growth and improved performance in FY’26, driven by advancements in the Specialty Chemicals and Nutrition businesses, and expected recovery in Acetyls portfolio.

Key Highlights

1. 1

   54% YoY increase in profit after tax

2. 2

   Double-digit growth in specialty chemicals

3. 3

   Global chemical sector emerging from inventory de-stocking phase

4. 4

   Specialty chemicals seeing volume growth, commodity segments facing demand challenges

5. 5

   Pharmaceutical end-use market continues to show steady growth

6. 6

   Agrochemical sector continues its upward momentum

7. 7

   Nutrition market saw stable volumes

8. 8

   Anticipated continued growth and improved performance in FY’26

9. 9

   Commitment to Lean 2.0 cost-efficiency initiatives

10. 10

    On track to deliver big CDMO order in early 2026